CREBBP (Gouveia et al., 2017), NFE2L2 (Kidani et al., 2020) and PARP1 (Liu et al., 2021) are known for their roles in the pathogenesis of stroke and post-stroke neurovascular remodeling and functional recovery. This evidence concerns the gene NFE2L2 and stroke disorder.